Pharmaceutical Technology

MAY 15, 2023

Innovation S-curve for the pharmaceutical industry Peptide nano-particle conjugates is a key innovation area in the pharmaceutical industry By tagging peptides with nanoparticles, peptide nano-particle conjugates allow enhanced control over their biological behaviour, overcoming intrinsic limitations of the individual materials.

Pharmaceutical 52

Pharmaceutical Leads Biopharma Medicine 52

PM360

APRIL 22, 2024

The imperative for a robust evidence generation and dissemination strategy tailored to the diverse needs of stakeholders looms large. From the initial stages of drug development to post-launch activities, the use of data, analytics, and insights will redefine how Medical Affairs demonstrates its impact.

Medical 52

Medical Healthcare Healthcare Education 52

Copyright Clearance Center

NOVEMBER 7, 2023

Researchers need easier ways to access the latest clinical evidence and identify trends within the data for a multitude of use cases across the drug development lifecycle,” said Tracey Armstrong, President and CEO, CCC. The new connector expands users’ access to this data from around the world.

Management 115

Management 115

European Pharmaceutical Review

NOVEMBER 10, 2022

Complex medicines offer diverse therapeutic modalities, including RNA therapeutics and antibody-drug conjugates (ADCs). With the new modalities used to treat disease and address previously undruggable targets, advanced drug delivery systems are critical to ensure targeted delivery, and to maximise safety and efficacy.

Medicine 99

Medicine Distribution Engineering Electronics 99